GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LTS:0R1F) » Definitions » EV-to-FCF

Bristol-Myers Squibb Co (LTS:0R1F) EV-to-FCF

: 10.04 (As of Today)
View and export this data going back to 2018. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bristol-Myers Squibb Co's Enterprise Value is $127,076 Mil. Bristol-Myers Squibb Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $12,651 Mil. Therefore, Bristol-Myers Squibb Co's EV-to-FCF for today is 10.04.

The historical rank and industry rank for Bristol-Myers Squibb Co's EV-to-FCF or its related term are showing as below:

LTS:0R1F' s EV-to-FCF Range Over the Past 10 Years
Min: 8.67   Med: 17.31   Max: 384.65
Current: 10.04

During the past 13 years, the highest EV-to-FCF of Bristol-Myers Squibb Co was 384.65. The lowest was 8.67. And the median was 17.31.

LTS:0R1F's EV-to-FCF is ranked better than
77.73% of 512 companies
in the Drug Manufacturers industry
Industry Median: 21.955 vs LTS:0R1F: 10.04

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-19), Bristol-Myers Squibb Co's stock price is $48.1525. Bristol-Myers Squibb Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.860. Therefore, Bristol-Myers Squibb Co's PE Ratio for today is 12.47.


Bristol-Myers Squibb Co EV-to-FCF Historical Data

The historical data trend for Bristol-Myers Squibb Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.77 13.01 10.68 15.13 10.51

Bristol-Myers Squibb Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.13 15.86 15.31 12.81 10.51

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co EV-to-FCF Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's EV-to-FCF falls into.



Bristol-Myers Squibb Co EV-to-FCF Calculation

Bristol-Myers Squibb Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=127076.446/12651
=10.04

Bristol-Myers Squibb Co's current Enterprise Value is $127,076 Mil.
Bristol-Myers Squibb Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12,651 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bristol-Myers Squibb Co  (LTS:0R1F) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bristol-Myers Squibb Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=48.1525/3.860
=12.47

Bristol-Myers Squibb Co's share price for today is $48.1525.
Bristol-Myers Squibb Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.860.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Bristol-Myers Squibb Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (LTS:0R1F) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (LTS:0R1F) Headlines

No Headlines